IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 226 filers reported holding IVERIC BIO INC in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $825 | +76.7% | 20,965 | +9.2% | 0.01% | +75.0% |
| Q1 2023 | $467 | -2.7% | 19,205 | -14.4% | 0.00% | 0.0% |
| Q4 2022 | $480 | -99.9% | 22,436 | +17.0% | 0.00% | +33.3% |
| Q3 2022 | $344,000 | +94.4% | 19,174 | +4.4% | 0.00% | +50.0% |
| Q2 2022 | $177,000 | -29.2% | 18,362 | +23.5% | 0.00% | 0.0% |
| Q1 2022 | $250,000 | -53.0% | 14,862 | -53.3% | 0.00% | 0.0% |
| Q4 2021 | $532,000 | +124.5% | 31,850 | +118.2% | 0.00% | 0.0% |
| Q3 2021 | $237,000 | +175.6% | 14,598 | +7.3% | 0.00% | +100.0% |
| Q2 2021 | $86,000 | – | 13,601 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Beryl Capital Management LLC | 5,339,518 | $210,056,638 | 52.85% |
| Chicago Capital Management, LLC | 359,561 | $14,145,130 | 18.12% |
| TCG Crossover Management, LLC | 2,448,829 | $96,336,933 | 15.80% |
| Vazirani Asset Management LLC | 180,000 | $7,081,200 | 11.94% |
| SYQUANT CAPITAL SAS | 406,686 | $15,999 | 11.62% |
| KRYGER CAPITAL Ltd | 2,523,853 | $99,288,377 | 10.16% |
| MPM BioImpact LLC | 1,214,662 | $47,784,803 | 9.62% |
| FNY Investment Advisers, LLC | 180,106 | $7,085 | 8.98% |
| HARVEST MANAGEMENT LLC | 213,500 | $8,399,090 | 7.25% |
| PRECEPT MANAGEMENT LLC | 130,000 | $5,114,200 | 6.94% |